Medtronic (NYSE:MDT) announced its intention to separate its diabetes business into a new, standalone company, to enhance focus on high-margin growth drivers for Medtronic and accelerate innovation ...

Diabetes is characterized by the pancreas producing too little insulin, but there is a rarer condition in which it produces ...

Discover 5 genius food strategies that naturally melt liver fat and boost weight loss. Science-backed nutrition tips for ...

The good news is that insulin resistance can be treated with lifestyle changes. One surprisingly simple change is choosing ...

Assembly Bill 555 would prohibit private insurance companies from charging people more than $35 for a 30-day supply of a ...

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech ...

Hormonal imbalances often hide behind seemingly unrelated symptoms. Learn the 4 telltale indicators your body's chemical ...

Some say that Ozempic can lead to surprise pregnancies, referred to as "Ozempic babies," by increasing fertility. Learn what the research says and the risks of taking it during pregnancy.

New research has linked ultra-processed foods to heart disease and Parkinson's disease. Here's what to know about the science ...

Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.